ellie md glp 1 reviews EllieMD EllieMD compounds GLP-1 and GLP-1/GIP

This highlights the potential impact of effective treatment for obesity in improving long term outcomes, especially when combined with other lifestyle interventions such as diet and exercise changes

A multicenter phase IIb RCT in NASH with fibrosis stages 1-3 demonstrated the efficacy of resmetirom in reducing hepatic steatosis at 12 and 36 weeks compared with placebo

Research Insight: The central nervous system effects of GLP-1, particularly on appetite regulation and reward pathways, are well-documented, showing a direct reduction in caloric intake

Ultimately, the decision to continue or discontinue GLP-1 therapy should be individualized, considering treatment response, tolerability, patient preferences, cost, and overall health status